Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Hematopoietic Stem Cell Transplant
Interventions
DRUG

2'-fucosyllactose

2FL powder will be provided to participants randomized to receive 2FL in packets. They will be instructed to drink this daily by adding the required amount to food or drink. It may also be mixed in standard feeds or mixed with water and administered by enteral tube, whenever applicable.

Trial Locations (1)

45229

Cincinnati Children's Hospital, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER